---
title: "enVVeno Medical wins FDA IDE approval for enVVe pivotal trial in deep venous insufficiency"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297191037.md"
description: "enVVeno Medical received FDA IDE clearance for the enVVe pivotal trial, a U.S. study of its bioprosthetic venous valve system for deep venous insufficiency. The TAVVE trial is scheduled to begin in Q4 2026, targeting approximately 230 patients across up to 40 U.S. sites."
datetime: "2026-08-27T13:03:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297191037.md)
  - [en](https://longbridge.com/en/news/297191037.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297191037.md)
generator: "portal-rs"
---

# enVVeno Medical wins FDA IDE approval for enVVe pivotal trial in deep venous insufficiency

-   enVVeno Medical received FDA IDE clearance for a U.S. pivotal study of its enVVe bioprosthetic venous valve system. \* TAVVE trial slated to start in Q4 2026; targets about 230 patients at up to 40 U.S. sites. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. enVVeno Medical Corp. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608270901ACCESSWRNAPR\_\_\_\_\_1213053) on August 27, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [NVNO.US](https://longbridge.com/en/quote/NVNO.US.md)

## Related News & Research

- [enVVeno Medical wins first US patent covering enVVe system](https://longbridge.com/en/news/292768101.md)
- [enVVeno Medical wins U.S. patent covering enVVe transcatheter venous valve system](https://longbridge.com/en/news/291932701.md)
- [Amadeus IT Group (BME:AMS) Could Be 13% Below Fair Value As EPS Rises 7.3%](https://longbridge.com/en/news/298155503.md)
- [Tennor Therapeutics wins China NMPA clearance for TNP-2092 phase IIb PJI trial](https://longbridge.com/en/news/298144467.md)
- [Royal Caribbean Group announces dividend of R$ 0.27 per unit, payable Oct. 15](https://longbridge.com/en/news/297928955.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**